Clinical Trial Update: Elimination of Albumin-Bound Substances by MARS and Prometheus [NA]

View source ↗

Summary

The trial update reports completion of a study evaluating the elimination of albumin-bound substances using MARS and Prometheus in patients with liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• MARS (Molecular Adsorbent Recirculating System)
• Prometheus

Snippet

Sponsor: Medical University of Graz | Conditions: Liver Failure | NA | Status: COMPLETED